A detailed history of Tower Research Capital LLC (Trc) transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,462 shares of KYMR stock, worth $103,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,462
Previous 13,125 81.24%
Holding current value
$103,305
Previous $391,000 70.33%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.16 - $52.4 $321,596 - $558,741
-10,663 Reduced 81.24%
2,462 $116,000
Q2 2024

Aug 13, 2024

BUY
$29.85 - $39.42 $370,766 - $489,635
12,421 Added 1764.35%
13,125 $391,000
Q1 2024

May 15, 2024

SELL
$22.9 - $43.57 $46,922 - $89,274
-2,049 Reduced 74.43%
704 $28,000
Q4 2023

Feb 13, 2024

SELL
$10.97 - $26.84 $42,772 - $104,649
-3,899 Reduced 58.61%
2,753 $70,000
Q3 2023

Nov 14, 2023

BUY
$13.9 - $23.88 $52,166 - $89,621
3,753 Added 129.46%
6,652 $92,000
Q2 2023

Aug 14, 2023

BUY
$22.4 - $34.92 $25,670 - $40,018
1,146 Added 65.37%
2,899 $66,000
Q1 2023

May 09, 2023

SELL
$24.84 - $38.75 $90,566 - $141,282
-3,646 Reduced 67.53%
1,753 $52,000
Q4 2022

Feb 10, 2023

SELL
$19.57 - $30.92 $258,774 - $408,855
-13,223 Reduced 71.01%
5,399 $135,000
Q3 2022

Nov 10, 2022

BUY
$20.91 - $34.27 $148,314 - $243,077
7,093 Added 61.52%
18,622 $405,000
Q2 2022

Aug 15, 2022

BUY
$14.13 - $42.55 $118,169 - $355,845
8,363 Added 264.15%
11,529 $227,000
Q1 2022

May 12, 2022

SELL
$35.3 - $64.68 $51,184 - $93,786
-1,450 Reduced 31.41%
3,166 $134,000
Q4 2021

Feb 14, 2022

BUY
$49.91 - $65.56 $45,418 - $59,659
910 Added 24.55%
4,616 $293,000
Q3 2021

Nov 15, 2021

BUY
$47.8 - $66.66 $94,930 - $132,386
1,986 Added 115.47%
3,706 $218,000
Q2 2021

Aug 16, 2021

BUY
$31.08 - $51.95 $7,334 - $12,260
236 Added 15.9%
1,720 $83,000
Q1 2021

May 17, 2021

BUY
$35.64 - $85.46 $26,159 - $62,727
734 Added 97.87%
1,484 $58,000
Q4 2020

Feb 16, 2021

SELL
$28.07 - $87.83 $6,175 - $19,322
-220 Reduced 22.68%
750 $47,000
Q3 2020

Nov 16, 2020

BUY
$26.1 - $33.28 $25,317 - $32,281
970 New
970 $31,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.3B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.